| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 64484 |
|
1,014 |
967 |
$212K |
| 64483 |
|
1,011 |
964 |
$145K |
| 62323 |
|
1,859 |
1,835 |
$107K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,236 |
2,151 |
$71K |
| 64635 |
|
389 |
384 |
$70K |
| 64636 |
|
422 |
358 |
$55K |
| 27096 |
|
448 |
336 |
$31K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,971 |
2,633 |
$20K |
| 20610 |
|
914 |
719 |
$18K |
| J3304 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
45 |
24 |
$18K |
| 62321 |
|
246 |
245 |
$17K |
| 64493 |
|
214 |
184 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
212 |
210 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
742 |
722 |
$9K |
| 64494 |
|
215 |
185 |
$7K |
| 99442 |
|
47 |
45 |
$2K |
| 64495 |
|
29 |
28 |
$2K |
| 64615 |
|
26 |
25 |
$948.12 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
43 |
41 |
$803.36 |
| 99000 |
|
443 |
432 |
$0.00 |